FacebookTwitterYoutubeInstagramGoogle Plus

Our Genome Ourselves

Thursday, June 3, 2010
8:00 pm - 9:30 pm

There is a revolution underway in the world of medicine. As researchers identify the genetic variants responsible for cancer, schizophrenia and diabetes, and doctors tailor medications and diagnostic tests specifically for your genomic makeup, we inch closer to personalized medicine. But what does this mean for you today? And how will it impact your health care 10, 20 or 30 years in the future? ABC’s Richard Besser joins Francis Collins, George Church and Robert C. Green. They look over the leading edge of genomics research to learn the promise, pitfalls, and realities barreling toward us.

Moderator

Richard BesserPhysician, Journalist

Richard Besser is ABC News’ chief health and medical editor. In this role, he provides medical analysis and commentary for all ABC News broadcasts and platforms, including World News with David Muir, Good Morning America, and Nightline.

Read More

Participants

Adam ColeSinger

A YouTube sensation with his video hit, “A Biologist’s Mother’s Day Song,” Adam Cole is a soon-to-be-unemployed college student born and raised in Oregon. He has studied everything from snake pheromones to intertidal biomechanics to genes involved with adenocarcinomas.

Read More
George ChurchGeneticist

George Church is professor of genetics at Harvard Medical School and director of PersonalGenomes.org, providing the world’s only open-access information on human Genomic, Environmental, and Trait data (GET). His 1984 Harvard Ph.D. included the first methods for direct genome sequencing, molecular multiplexing, and barcoding.

Read More
Francis CollinsGeneticist, Physician

Francis Collins is known for his landmark discoveries of disease genes and leadership of the Human Genome Project, an international project that culminated in 2003 with the completion of a finished sequence of the human DNA instruction book.

Read More
Robert C. GreenGeneticist

Robert C. Green is a medical geneticist who directs the G2P Research Program (genomes2people.org) in translational genomics and health outcomes at Brigham and Women’s Hospital and Harvard Medical School. He has been continuously funded by NIH for over 26 years and has published over 300 scientific articles.

Read More